Yoav Golan

7.8k total citations · 3 hit papers
73 papers, 5.4k citations indexed

About

Yoav Golan is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Yoav Golan has authored 73 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 27 papers in Epidemiology and 13 papers in Clinical Biochemistry. Recurrent topics in Yoav Golan's work include Clostridium difficile and Clostridium perfringens research (20 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Microscopic Colitis (12 papers). Yoav Golan is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (20 papers), Bacterial Identification and Susceptibility Testing (13 papers) and Microscopic Colitis (12 papers). Yoav Golan collaborates with scholars based in United States, Israel and Canada. Yoav Golan's co-authors include Thomas Louie, Kathleen M. Mullane, Mark A. Miller, Arnold Lentnek, Karl Heinz Weiss, Sherwood L. Gorbach, Youe‐Kong Shue, P.S. Sears, Doron Lancet and Greg Stelzer and has published in prestigious journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.

In The Last Decade

Yoav Golan

73 papers receiving 5.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

GeneCards Version 3: the human gene integrator

2010 1.5k citations Marilyn Safran, Jake M. Alexander et al. Database profile →
Fidaxomicin versus Vancomycin for Clostridium difficile Infection

2011 1.1k citations Thomas Louie, Mark A. Miller et al. profile →
VE303, a Defined Bacterial Consortium, for Prevention of Recurrent Clostridioides difficile Infection

2023 120 citations Thomas Louie, Yoav Golan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoav Golan United States	31	2.9k	2.2k	1.2k	688	577	73	5.4k
Jun Yong Choi South Korea	41	2.8k 1.0×	2.5k 1.2×	967 0.8×	630 0.9×	418 0.7×	491	7.5k
Susan Whittier United States	41	1.9k 0.7×	1.5k 0.7×	820 0.7×	391 0.6×	531 0.9×	118	4.7k
Robert Krause Austria	41	3.2k 1.1×	3.0k 1.4×	647 0.5×	328 0.5×	296 0.5×	164	5.4k
Carlo Tascini Italy	38	2.2k 0.8×	1.8k 0.8×	548 0.5×	627 0.9×	372 0.6×	263	5.2k
Martin Llewelyn United Kingdom	30	1.8k 0.6×	1.2k 0.6×	810 0.7×	419 0.6×	697 1.2×	95	4.0k
Kenneth H. Rand United States	38	1.5k 0.5×	2.0k 0.9×	794 0.7×	454 0.7×	681 1.2×	122	4.7k
Martín E. Stryjewski United States	35	2.9k 1.0×	1.5k 0.7×	996 0.8×	424 0.6×	1.4k 2.5×	80	4.6k
Heungsup Sung South Korea	33	2.6k 0.9×	2.6k 1.2×	622 0.5×	461 0.7×	291 0.5×	275	5.6k
Bhanu Sinha Netherlands	43	2.4k 0.8×	1.3k 0.6×	2.4k 2.0×	757 1.1×	611 1.1×	135	6.0k
Sang‐Ho Choi South Korea	46	3.6k 1.3×	3.5k 1.6×	870 0.7×	1.3k 1.9×	823 1.4×	414	8.0k

Countries citing papers authored by Yoav Golan

Since Specialization

Citations

This map shows the geographic impact of Yoav Golan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoav Golan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoav Golan more than expected).

Fields of papers citing papers by Yoav Golan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoav Golan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoav Golan. The network helps show where Yoav Golan may publish in the future.

Co-authorship network of co-authors of Yoav Golan

This figure shows the co-authorship network connecting the top 25 collaborators of Yoav Golan. A scholar is included among the top collaborators of Yoav Golan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoav Golan. Yoav Golan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Golan, Yoav, et al.. (2022). SIMJig - Smart Independent Minimalist Jig. IEEE Robotics and Automation Letters. 7(2). 3396–3403. 1 indexed citations

Golan, Yoav, Yuexin Tang, Shahrul Mt‐Isa, et al.. (2021). Impact of Letermovir Use for Cytomegalovirus Prophylaxis on Re-Hospitalization Following Allogeneic Hematopoietic Stem Cell Transplantation: An Analysis of a Phase III Randomized Clinical Trial. PharmacoEconomics - Open. 5(3). 469–473. 9 indexed citations

Golan, Yoav, Amir Shapiro, & Elon Rimon. (2020). Jamming-Free Immobilizing Grasps Using Dual-Friction Robotic Fingertips. IEEE Robotics and Automation Letters. 5(2). 2889–2896. 9 indexed citations

Golan, Yoav, Amir Shapiro, & Elon Rimon. (2020). A Variable-Structure Robot Hand That Uses the Environment to Achieve General Purpose Grasps. IEEE Robotics and Automation Letters. 5(3). 4804–4811. 6 indexed citations

Basu, Anirban, Vimalanand S. Prabhu, Marcus Dörr, et al.. (2018). Bezlotoxumab Is Associated With a Reduction in Cumulative Inpatient-Days: Analysis of the Hospitalization Data From the MODIFY I and II Clinical Trials. Open Forum Infectious Diseases. 5(11). ofy218–ofy218. 6 indexed citations

Rimon, Elon, et al.. (2018). Caging Polygonal Objects Using Formationally Similar Three-Finger Hands. IEEE Robotics and Automation Letters. 3(4). 3271–3278. 7 indexed citations

Golan, Yoav. (2015). Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options. BMC Infectious Diseases. 15(1). 313–313. 40 indexed citations

Weston, Allan P., Yoav Golan, Christina Holcroft, & David R. Snydman. (2014). The Efficacy of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infection in Patients With Impaired Renal Function. Clinical Infectious Diseases. 58(11). 1533–1539. 13 indexed citations

Miller, Mark A., Thomas Louie, Kathleen M. Mullane, et al.. (2013). Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infectious Diseases. 13(1). 148–148. 116 indexed citations

10.

Snydman, David R., N V Jacobus, Yoav Golan, et al.. (2010). Lessons Learned from the Anaerobe Survey: Historical Perspective and Review of the Most Recent Data (2005–2007). Clinical Infectious Diseases. 50(s1). S26–S33. 110 indexed citations

11.

Chow, Jennifer, György Frendl, Susan Hadley, et al.. (2010). Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?. Journal of Antimicrobial Chemotherapy. 65(7). 1460–1465. 82 indexed citations

12.

Safran, Marilyn, Jake M. Alexander, Naomi Rosen, et al.. (2010). GeneCards Version 3: the human gene integrator. Database. 2010(0). baq020–baq020. 1453 indexed citations breakdown →

13.

Marchaim, Dror, Keith S. Kaye, Vance G. Fowler, et al.. (2009). Case–control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. Clinical Microbiology and Infection. 16(6). 747–752. 48 indexed citations

14.

Drees, Marci, David R. Snydman, Christopher H. Schmid, et al.. (2008). Prior Environmental Contamination Increases the Risk of Acquisition of Vancomycin-Resistant Enterococci. Clinical Infectious Diseases. 46(5). 678–685. 216 indexed citations

15.

Sakoulas, George, et al.. (2007). Daptomycin in the Treatment of Bacteremia. The American Journal of Medicine. 120(10). S21–S27. 39 indexed citations

16.

Golan, Yoav. (2006). Trends in Vancomycin (vanco) Susceptibility (S) among Consecutive MRSA Bacteremia Isolates. 2 indexed citations

17.

Golan, Yoav, Shira Doron, John Griffith, et al.. (2006). The Impact of Gown-Use Requirement on Hand Hygiene Compliance. Clinical Infectious Diseases. 42(3). 370–376. 46 indexed citations

18.

Giladi, Michael, Y. Kletter, Boaz Avidor, et al.. (2001). Enzyme Immunoassay for the Diagnosis of Cat‐Scratch Disease Defined by Polymerase Chain Reaction. Clinical Infectious Diseases. 33(11). 1852–1858. 56 indexed citations

19.

Schwartz, Doron, Ran Kornowski, Idit F. Schwartz, et al.. (1996). Prediction of renal impairment in elderly patients with congestive heart failure treated with captopril. Cardiovascular Drugs and Therapy. 10(1). 75–79. 3 indexed citations

20.

Baruchin, A.M., Oded Nahlieli, & Yoav Golan. (1992). Oculo-cerebro-cutaneous syndrome: First description in an adult. Journal of Cranio-Maxillofacial Surgery. 20(2). 70–72. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact